Replies to post #409676 on Anavex Life Sciences Corp (AVXL)

[abew4me]

NO. You're way off base.

Once they commercialize A2-73 for Rett, they will be generating at least $40 - $50 Million/year in net revenue...assuming they treat 50% of the Rett patients in the U.S. alone.

See my post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171604618

My opinion. Do not use my comments to buy or sell shares of AVXL